Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients: Pooled Analysis of Four Phase 3 Studies
Crossref DOI link: https://doi.org/10.1007/s13555-017-0211-4
Published Online: 2017-12-07
Published Print: 2018-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pariser, David
Frankel, Ellen
Schlessinger, Joel
Poulin, Yves
Vender, Ronald
Langley, Richard G.
Meng, Xiangyi
Guana, Adriana
Nyirady, Judit